UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT Pursuant to

Section 13 OR 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 16, 2015

 

 

 
Medytox Solutions, Inc.
(Exact name of registrant as specified in its charter)

 

Nevada  000-54346  90-0902741
(State or Other jurisdiction of Incorporation)  (Commission File Number)  (IRS Employer Identification No.)

 

     

400 S. Australian Avenue

Suite 800

West Palm Beach, Florida

  33401
(Address of Principal Executive Offices)   (Zip Code)

 

 
561-855-1626
(Registrant’s telephone number, including area code)

 

 
Not Applicable
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[X] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[   ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[   ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[   ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 
 

Item 8.01. Other Events

 

On April 16, 2015, Medytox Solutions, Inc. (the "Company") issued a press release announcing that the Company entered into a definitive merger agreement with CollabRx, Inc. A copy of the press release is filed as Exhibit 99.1 to this report.

 

ITEM 9.01. Financial Statements and Exhibits

 

(d) Exhibits

 

   
Exhibit Number Description
99.1 Press Release, dated April 16, 2015.

 

 

 

 

 

 

 

 

 

 

 

2
 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

   
  MEDYTOX SOLUTIONS, INC.
   
   
Dated:  April 16, 2015 /s/ Seamus Lagan
  Seamus Lagan
 

Chief Executive Officer

(principal executive officer)

 

 

 

 

 

 

 

 

 

 

 

3
 

 

EXHIBIT INDEX

 

 

   
   
Exhibit Number Description
99.1 Press Release, dated April 16, 2015.

 

 

 

 

 

 

 

 

 

 

4